GlassScriptPhysician profile
Amanda Ferguson
NPI 1962959783
$5,690.10
in general payments reported to CMS, 2019-2025
42 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,491 · 2022: $1,529 · 2023: $1,973 · 2024: $498 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,670.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $780.43 | 2021-2025 | Xtandi, Vyloy, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $563.87 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $558.07 | 2023-2024 | Orgovyx, Gemtesa |
| Abbvie INC. | $530.32 | 2021-2024 | |
| Janssen Biotech, INC. | $328.72 | 2021-2023 | Erleada, Akeega |
| Pfizer INC. | $301.50 | 2021-2025 | |
| Myovant Sciences INC. | $264.82 | 2021-2022 | |
| Amgen INC. | $230.96 | 2021-2023 | Xgeva |
| Progenics Pharmaceuticals, INC. | $183.99 | 2022-2023 | Pylarify |
| Blue Earth Diagnostics | $163.93 | 2021-2023 | |
| Boston Scientific Corporation | $135.35 | 2021-2023 | Spaceoar Vue System - 10ml |
| Agios Pharmaceuticals, INC. | $117.12 | 2024 | Pyrukynd |
| Regeneron Healthcare Solutions, INC. | $112.49 | 2024 | Libtayo |
| Endo Pharmaceuticals INC. | $99.59 | 2021 | |
| Telix Pharmaceuticals | $97.01 | 2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.